Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report

The allogeneic therapeutic vaccine CSF-470 has demonstrated a significant benefit over medium-dose IFNα2b in the distant metastasis-free survival for stages IIB–IIC–III cutaneous melanoma patients in a randomized phase II/III clinical trial (CASVAC-0401, NCT01729663). At the end of the 2-year CSF-47...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Aris, Mariana, Bravo, Alicia Inés, Pampena, María Betina, Blanco, Paula Alejandra, Carri, Ibel, Koile, Daniel, Yankilevich, Patricio, Levy, Estrella Mariel, Barrio, María Marcela, Mordoh, José
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5944263/
https://ncbi.nlm.nih.gov/pubmed/29774030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.00955
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados